Patrick M. Caldwell is CFO at BIOSPECIFICS TECHNOLOGIES CORP (BSTC). They have made 1 open-market trade across 1 company since 2019, most recently 2019-10-01.
CIK 0001242121
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BSTC | 1,000 | $89K |
Shares reported on the most recent Form 4, priced at the 2019-11-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BSTC | SELL | 2019-06-03 | 2019-06-05 | $58.80 | $353K | +0.3% | +4.2% | -6.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.